CA3028334A1 - Engineered parasites for delivering protein to the central nervous system (cns) - Google Patents

Info

Publication number

CA3028334A1

CA3028334A1 CA3028334A CA3028334A CA3028334A1 CA 3028334 A1 CA3028334 A1 CA 3028334A1 CA 3028334 A CA3028334 A CA 3028334A CA 3028334 A CA3028334 A CA 3028334A CA 3028334 A1 CA3028334 A1 CA 3028334A1

Authority

CA

Canada

Prior art keywords

tgme49

length

chr

toxoplasma

nucleic acid

Prior art date

2016-06-29

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 210000003169 central nervous system Anatomy 0.000 title claims abstract description 52
• 108090000623 proteins and genes Proteins 0.000 title claims description 551
• 102000004169 proteins and genes Human genes 0.000 title claims description 324
• 244000045947 parasite Species 0.000 title description 145
• 241000223996 Toxoplasma Species 0.000 claims abstract description 204
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 150
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 123
• 229920001184 polypeptide Polymers 0.000 claims abstract description 122
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 122
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 100
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 100
• 238000000034 method Methods 0.000 claims abstract description 76
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 42
• 230000007170 pathology Effects 0.000 claims abstract description 39
• 241000223997 Toxoplasma gondii Species 0.000 claims description 339
• 210000004027 cell Anatomy 0.000 claims description 123
• 239000008187 granular material Substances 0.000 claims description 103
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 54
• 102000040430 polynucleotide Human genes 0.000 claims description 50
• 108091033319 polynucleotide Proteins 0.000 claims description 50
• 239000002157 polynucleotide Substances 0.000 claims description 50
• 239000003814 drug Substances 0.000 claims description 35
• 229940079593 drug Drugs 0.000 claims description 30
• 230000001939 inductive effect Effects 0.000 claims description 30
• 108091026890 Coding region Proteins 0.000 claims description 27
• 238000011144 upstream manufacturing Methods 0.000 claims description 25
• 239000003550 marker Substances 0.000 claims description 24
• 108010022394 Threonine synthase Proteins 0.000 claims description 17
• 108091023045 Untranslated Region Proteins 0.000 claims description 16
• 238000013518 transcription Methods 0.000 claims description 16
• 230000001506 immunosuppresive effect Effects 0.000 claims description 15
• 230000035897 transcription Effects 0.000 claims description 15
• 206010062016 Immunosuppression Diseases 0.000 claims description 14
• 230000002950 deficient Effects 0.000 claims description 13
• 239000003795 chemical substances by application Substances 0.000 claims description 12
• 230000002238 attenuated effect Effects 0.000 claims description 11
• 230000003115 biocidal effect Effects 0.000 claims description 10
• 230000001018 virulence Effects 0.000 claims description 10
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 claims description 8
• 108091006047 fluorescent proteins Proteins 0.000 claims description 7
• 102000034287 fluorescent proteins Human genes 0.000 claims description 7
• 239000003242 anti bacterial agent Substances 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 6
• 238000003776 cleavage reaction Methods 0.000 claims description 5
• 108010051219 Cre recombinase Proteins 0.000 claims description 4
• 101000807008 Homo sapiens Uracil phosphoribosyltransferase homolog Proteins 0.000 claims description 4
• 101000938863 Toxoplasma gondii Uracil phosphoribosyltransferase Proteins 0.000 claims description 4
• 102100037717 Uracil phosphoribosyltransferase homolog Human genes 0.000 claims description 4
• 230000004044 response Effects 0.000 claims description 4
• 230000007017 scission Effects 0.000 claims description 4
• 239000003053 toxin Substances 0.000 claims description 4
• 231100000765 toxin Toxicity 0.000 claims description 4
• 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 claims description 3
• 230000010354 integration Effects 0.000 claims description 3
• 125000003275 alpha amino acid group Chemical group 0.000 claims 3
• 101100091482 Caenorhabditis elegans rop-1 gene Proteins 0.000 claims 1
• 102000009073 Macrophage Migration-Inhibitory Factors Human genes 0.000 claims 1
• 230000001225 therapeutic effect Effects 0.000 abstract description 70
• 210000000349 chromosome Anatomy 0.000 description 153
• 230000009261 transgenic effect Effects 0.000 description 65
• 108010029485 Protein Isoforms Proteins 0.000 description 57
• 102000001708 Protein Isoforms Human genes 0.000 description 57
• 108020004705 Codon Proteins 0.000 description 42
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 42
• 102100028496 Galactocerebrosidase Human genes 0.000 description 41
• 108010042681 Galactosylceramidase Proteins 0.000 description 41
• 206010021143 Hypoxia Diseases 0.000 description 41
• 230000001146 hypoxic effect Effects 0.000 description 41
• 230000000302 ischemic effect Effects 0.000 description 41
• 208000015114 central nervous system disease Diseases 0.000 description 40
• 208000036110 Neuroinflammatory disease Diseases 0.000 description 38
• 230000000626 neurodegenerative effect Effects 0.000 description 38
• 108091000080 Phosphotransferase Proteins 0.000 description 37
• 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 37
• 230000014509 gene expression Effects 0.000 description 37
• 102000020233 phosphotransferase Human genes 0.000 description 37
• 108091009877 methyl-CpG binding proteins Proteins 0.000 description 36
• 102100033130 T-box transcription factor T Human genes 0.000 description 34
• 101710086566 T-box transcription factor T Proteins 0.000 description 34
• 208000024827 Alzheimer disease Diseases 0.000 description 33
• 108700026244 Open Reading Frames Proteins 0.000 description 33
• 208000018737 Parkinson disease Diseases 0.000 description 33
• 102000031635 methyl-CpG binding proteins Human genes 0.000 description 33
• 108700023155 Aspartoacylases Proteins 0.000 description 32
• 208000030886 Traumatic Brain injury Diseases 0.000 description 32
• 102000018919 aspartoacylase Human genes 0.000 description 32
• 230000003247 decreasing effect Effects 0.000 description 32
• 230000009529 traumatic brain injury Effects 0.000 description 32
• 210000001519 tissue Anatomy 0.000 description 31
• 108020005345 3' Untranslated Regions Proteins 0.000 description 30
• 201000010099 disease Diseases 0.000 description 30
• 108020003589 5' Untranslated Regions Proteins 0.000 description 29
• 241000282414 Homo sapiens Species 0.000 description 29
• 108020001507 fusion proteins Proteins 0.000 description 28
• 102000037865 fusion proteins Human genes 0.000 description 27
• 208000015181 infectious disease Diseases 0.000 description 27
• 125000003729 nucleotide group Chemical group 0.000 description 27
• 230000008499 blood brain barrier function Effects 0.000 description 26
• 210000001218 blood-brain barrier Anatomy 0.000 description 26
• 108010072388 Methyl-CpG-Binding Protein 2 Proteins 0.000 description 25
• 210000002569 neuron Anatomy 0.000 description 25
• 239000002773 nucleotide Substances 0.000 description 25
• 102100039124 Methyl-CpG-binding protein 2 Human genes 0.000 description 24
• 101710162524 Transcription factor EB Proteins 0.000 description 24
• 230000028327 secretion Effects 0.000 description 24
• 102100028502 Transcription factor EB Human genes 0.000 description 23
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 22
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 22
• 206010028980 Neoplasm Diseases 0.000 description 22
• 208000031513 cyst Diseases 0.000 description 22
• 230000000694 effects Effects 0.000 description 22
• 239000000203 mixture Substances 0.000 description 22
• 210000000059 tachyzoite Anatomy 0.000 description 22
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 21
• 210000000061 bradyzoite Anatomy 0.000 description 20
• 210000004556 brain Anatomy 0.000 description 20
• 210000004940 nucleus Anatomy 0.000 description 20
• 208000006289 Rett Syndrome Diseases 0.000 description 19
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 18
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 18
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 18
• 208000028226 Krabbe disease Diseases 0.000 description 18
• 238000013459 approach Methods 0.000 description 18
• 210000003463 organelle Anatomy 0.000 description 18
• 102000045222 parkin Human genes 0.000 description 18
• 108020004414 DNA Proteins 0.000 description 17
• 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 17
• 150000001413 amino acids Chemical group 0.000 description 17
• 230000003197 catalytic effect Effects 0.000 description 17
• 230000004927 fusion Effects 0.000 description 17
• 230000008685 targeting Effects 0.000 description 17
• 239000004480 active ingredient Substances 0.000 description 16
• 210000003618 cortical neuron Anatomy 0.000 description 16
• 210000004929 secretory organelle Anatomy 0.000 description 16
• 238000010171 animal model Methods 0.000 description 15
• 230000001105 regulatory effect Effects 0.000 description 15
• 241001465754 Metazoa Species 0.000 description 14
• 102000048238 Neuregulin-1 Human genes 0.000 description 14
• 108090000556 Neuregulin-1 Proteins 0.000 description 14
• 102100021947 Survival motor neuron protein Human genes 0.000 description 14
• 101001053395 Arabidopsis thaliana Acid beta-fructofuranosidase 4, vacuolar Proteins 0.000 description 13
• 108700010070 Codon Usage Proteins 0.000 description 13
• 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 13
• 101710171779 Survival motor neuron protein Proteins 0.000 description 13
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 13
• 230000004807 localization Effects 0.000 description 13
• 210000003934 vacuole Anatomy 0.000 description 13
• 101150073248 GRA2 gene Proteins 0.000 description 12
• 238000003556 assay Methods 0.000 description 12
• 208000037062 Polyps Diseases 0.000 description 11
• 210000002950 fibroblast Anatomy 0.000 description 11
• 239000000047 product Substances 0.000 description 11
• 238000011282 treatment Methods 0.000 description 11
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 10
• 210000003855 cell nucleus Anatomy 0.000 description 10
• 239000007924 injection Substances 0.000 description 10
• 238000002347 injection Methods 0.000 description 10
• 239000000178 monomer Substances 0.000 description 10
• 108090000144 Human Proteins Proteins 0.000 description 9
• 102000003839 Human Proteins Human genes 0.000 description 9
• 208000037581 Persistent Infection Diseases 0.000 description 9
• 150000001875 compounds Chemical class 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 230000003834 intracellular effect Effects 0.000 description 9
• 230000000670 limiting effect Effects 0.000 description 9
• 210000004962 mammalian cell Anatomy 0.000 description 9
• 210000004379 membrane Anatomy 0.000 description 9
• 239000012528 membrane Substances 0.000 description 9
• 238000012986 modification Methods 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 8
• 101100056797 Canis lupus familiaris SAG gene Proteins 0.000 description 8
• 206010011732 Cyst Diseases 0.000 description 8
• 102100024746 Dihydrofolate reductase Human genes 0.000 description 8
• 101710163270 Nuclease Proteins 0.000 description 8
• 101100532512 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SAG1 gene Proteins 0.000 description 8
• 101150063416 add gene Proteins 0.000 description 8
• 238000004113 cell culture Methods 0.000 description 8
• 108020001096 dihydrofolate reductase Proteins 0.000 description 8
• 208000035475 disorder Diseases 0.000 description 8
• 238000009826 distribution Methods 0.000 description 8
• 238000002474 experimental method Methods 0.000 description 8
• 238000003125 immunofluorescent labeling Methods 0.000 description 8
• 238000000338 in vitro Methods 0.000 description 8
• 239000000463 material Substances 0.000 description 8
• 230000007246 mechanism Effects 0.000 description 8
• 230000004048 modification Effects 0.000 description 8
• 201000006417 multiple sclerosis Diseases 0.000 description 8
• 230000001537 neural effect Effects 0.000 description 8
• 239000000243 solution Substances 0.000 description 8
• 241000894007 species Species 0.000 description 8
• 238000010186 staining Methods 0.000 description 8
• 239000013598 vector Substances 0.000 description 8
• 208000030507 AIDS Diseases 0.000 description 7
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
• 208000023105 Huntington disease Diseases 0.000 description 7
• 230000001154 acute effect Effects 0.000 description 7
• 230000001413 cellular effect Effects 0.000 description 7
• 238000011161 development Methods 0.000 description 7
• 238000005516 engineering process Methods 0.000 description 7
• 239000000725 suspension Substances 0.000 description 7
• 238000012360 testing method Methods 0.000 description 7
• 230000014616 translation Effects 0.000 description 7
• 230000032258 transport Effects 0.000 description 7
• 230000000472 traumatic effect Effects 0.000 description 7
• 102100034613 Annexin A2 Human genes 0.000 description 6
• 101100523504 Arabidopsis thaliana ARAC6 gene Proteins 0.000 description 6
• 101001053401 Arabidopsis thaliana Acid beta-fructofuranosidase 3, vacuolar Proteins 0.000 description 6
• 230000004568 DNA-binding Effects 0.000 description 6
• 102000004190 Enzymes Human genes 0.000 description 6
• 108090000790 Enzymes Proteins 0.000 description 6
• 102000012004 Ghrelin Human genes 0.000 description 6
• 101800001586 Ghrelin Proteins 0.000 description 6
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 6
• 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 6
• 101001019591 Homo sapiens Interleukin-18-binding protein Proteins 0.000 description 6
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 6
• 102100025947 Insulin-like growth factor II Human genes 0.000 description 6
• 102100035017 Interleukin-18-binding protein Human genes 0.000 description 6
• 101100523507 Oryza sativa subsp. japonica RAC7 gene Proteins 0.000 description 6
• 102000001253 Protein Kinase Human genes 0.000 description 6
• 101000871078 Toxoplasma gondii Dense granule protein 2 Proteins 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• 208000029028 brain injury Diseases 0.000 description 6
• 230000004069 differentiation Effects 0.000 description 6
• 239000013604 expression vector Substances 0.000 description 6
• 238000009472 formulation Methods 0.000 description 6
• 210000000987 immune system Anatomy 0.000 description 6
• 230000001771 impaired effect Effects 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 238000010369 molecular cloning Methods 0.000 description 6
• 230000002093 peripheral effect Effects 0.000 description 6
• 239000000546 pharmaceutical excipient Substances 0.000 description 6
• 239000013612 plasmid Substances 0.000 description 6
• 108060006633 protein kinase Proteins 0.000 description 6
• 230000002829 reductive effect Effects 0.000 description 6
• 230000003248 secreting effect Effects 0.000 description 6
• 102100027346 GTP cyclohydrolase 1 Human genes 0.000 description 5
• 108010010803 Gelatin Proteins 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 101000924474 Homo sapiens Annexin A2 Proteins 0.000 description 5
• 101000862581 Homo sapiens GTP cyclohydrolase 1 Proteins 0.000 description 5
• 101000950687 Homo sapiens Mitogen-activated protein kinase 7 Proteins 0.000 description 5
• 208000015439 Lysosomal storage disease Diseases 0.000 description 5
• 102100037805 Mitogen-activated protein kinase 7 Human genes 0.000 description 5
• 241000699670 Mus sp. Species 0.000 description 5
• 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 5
• 108010074596 Myosin-Light-Chain Kinase Proteins 0.000 description 5
• 229920002472 Starch Polymers 0.000 description 5
• 238000010459 TALEN Methods 0.000 description 5
• 201000005485 Toxoplasmosis Diseases 0.000 description 5
• 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 5
• 230000027455 binding Effects 0.000 description 5
• 239000002775 capsule Substances 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 108010039433 dolichos biflorus agglutinin Proteins 0.000 description 5
• 238000000799 fluorescence microscopy Methods 0.000 description 5
• 229920000159 gelatin Polymers 0.000 description 5
• 239000008273 gelatin Substances 0.000 description 5
• 235000019322 gelatine Nutrition 0.000 description 5
• 235000011852 gelatine desserts Nutrition 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 238000010362 genome editing Methods 0.000 description 5
• 238000003780 insertion Methods 0.000 description 5
• 230000037431 insertion Effects 0.000 description 5
• 230000000144 pharmacologic effect Effects 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 101100355577 Arabidopsis thaliana ARAC11 gene Proteins 0.000 description 4
• 102100037902 CD99 antigen Human genes 0.000 description 4
• 208000022526 Canavan disease Diseases 0.000 description 4
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 4
• 101001122938 Homo sapiens Lysosomal protective protein Proteins 0.000 description 4
• 101001121074 Homo sapiens MICOS complex subunit MIC13 Proteins 0.000 description 4
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 4
• 102100028524 Lysosomal protective protein Human genes 0.000 description 4
• 102100026627 MICOS complex subunit MIC13 Human genes 0.000 description 4
• 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 4
• 208000002678 Mucopolysaccharidoses Diseases 0.000 description 4
• 108700015679 Nested Genes Proteins 0.000 description 4
• 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 4
• 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 description 4
• 201000007737 Retinal degeneration Diseases 0.000 description 4
• 108091036066 Three prime untranslated region Proteins 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 230000003542 behavioural effect Effects 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 4
• 238000000749 co-immunoprecipitation Methods 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 230000006378 damage Effects 0.000 description 4
• 239000008298 dragée Substances 0.000 description 4
• 239000012636 effector Substances 0.000 description 4
• 108010026638 endodeoxyribonuclease FokI Proteins 0.000 description 4
• -1 foodstuff Substances 0.000 description 4
• 239000012634 fragment Substances 0.000 description 4
• 238000001990 intravenous administration Methods 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 230000004001 molecular interaction Effects 0.000 description 4
• 206010028093 mucopolysaccharidosis Diseases 0.000 description 4
• 208000005340 mucopolysaccharidosis III Diseases 0.000 description 4
• 208000011045 mucopolysaccharidosis type 3 Diseases 0.000 description 4
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 4
• 208000015122 neurodegenerative disease Diseases 0.000 description 4
• 210000004498 neuroglial cell Anatomy 0.000 description 4
• 230000007171 neuropathology Effects 0.000 description 4
• 210000003250 oocyst Anatomy 0.000 description 4
• 238000005457 optimization Methods 0.000 description 4
• 230000003071 parasitic effect Effects 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
• 230000004258 retinal degeneration Effects 0.000 description 4
• 239000003381 stabilizer Substances 0.000 description 4
• 235000019698 starch Nutrition 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 239000003826 tablet Substances 0.000 description 4
• 238000010361 transduction Methods 0.000 description 4
• 230000026683 transduction Effects 0.000 description 4
• 230000001052 transient effect Effects 0.000 description 4
• 229940075420 xanthine Drugs 0.000 description 4
• 108010020567 12E7 Antigen Proteins 0.000 description 3
• RJOXFJDOUQJOMQ-UHFFFAOYSA-N 6-sulfanylidene-3,7-dihydropurin-2-one Chemical compound S=C1NC(=O)NC2=C1NC=N2 RJOXFJDOUQJOMQ-UHFFFAOYSA-N 0.000 description 3
• 208000006515 AB Variant Tay-Sachs Disease Diseases 0.000 description 3
• 102100022385 Activity-dependent neuroprotector homeobox protein Human genes 0.000 description 3
• 239000012099 Alexa Fluor family Substances 0.000 description 3
• 208000019901 Anxiety disease Diseases 0.000 description 3
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 3
• 101100139843 Arabidopsis thaliana ARAC2 gene Proteins 0.000 description 3
• 101100523509 Arabidopsis thaliana ARAC9 gene Proteins 0.000 description 3
• 102100038238 Aromatic-L-amino-acid decarboxylase Human genes 0.000 description 3
• 206010003805 Autism Diseases 0.000 description 3
• 208000020706 Autistic disease Diseases 0.000 description 3
• 108091012583 BCL2 Proteins 0.000 description 3
• 102100026189 Beta-galactosidase Human genes 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• 108090000164 Carbamoyl-phosphate synthase (glutamine-hydrolyzing) Proteins 0.000 description 3
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
• 241000702421 Dependoparvovirus Species 0.000 description 3
• 208000001905 GM2 Gangliosidoses Diseases 0.000 description 3
• 102100035857 Glutamate decarboxylase 2 Human genes 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 101000755474 Homo sapiens Activity-dependent neuroprotector homeobox protein Proteins 0.000 description 3
• 101000765010 Homo sapiens Beta-galactosidase Proteins 0.000 description 3
• 101000873786 Homo sapiens Glutamate decarboxylase 2 Proteins 0.000 description 3
• 101000602167 Homo sapiens Neuroserpin Proteins 0.000 description 3
• 101000996058 Homo sapiens Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 Proteins 0.000 description 3
• 101001124867 Homo sapiens Peroxiredoxin-1 Proteins 0.000 description 3
• 101001092197 Homo sapiens RNA binding protein fox-1 homolog 3 Proteins 0.000 description 3
• 101150069138 HtrA2 gene Proteins 0.000 description 3
• 229940126049 IMC-1 Drugs 0.000 description 3
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
• 229930182816 L-glutamine Natural products 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 239000005089 Luciferase Substances 0.000 description 3
• 102000005741 Metalloproteases Human genes 0.000 description 3
• 108010006035 Metalloproteases Proteins 0.000 description 3
• 108010071382 NF-E2-Related Factor 2 Proteins 0.000 description 3
• 102100037591 Neuroserpin Human genes 0.000 description 3
• 102100034450 Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 Human genes 0.000 description 3
• 108010077850 Nuclear Localization Signals Proteins 0.000 description 3
• 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 description 3
• 102100037499 Parkinson disease protein 7 Human genes 0.000 description 3
• 102100029139 Peroxiredoxin-1 Human genes 0.000 description 3
• 108010032428 Protein Deglycase DJ-1 Proteins 0.000 description 3
• 102100035530 RNA binding protein fox-1 homolog 3 Human genes 0.000 description 3
• 102100021117 Serine protease HTRA2, mitochondrial Human genes 0.000 description 3
• 206010048327 Supranuclear palsy Diseases 0.000 description 3
• 239000000443 aerosol Substances 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 230000030570 cellular localization Effects 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 230000001010 compromised effect Effects 0.000 description 3
• 210000000805 cytoplasm Anatomy 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 238000012377 drug delivery Methods 0.000 description 3
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 3
• 238000009585 enzyme analysis Methods 0.000 description 3
• 238000002641 enzyme replacement therapy Methods 0.000 description 3
• 206010015037 epilepsy Diseases 0.000 description 3
• 239000012091 fetal bovine serum Substances 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 230000002518 glial effect Effects 0.000 description 3
• 239000005090 green fluorescent protein Substances 0.000 description 3
• 238000011997 immunoflourescence assay Methods 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 238000001802 infusion Methods 0.000 description 3
• 230000002401 inhibitory effect Effects 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 108020004999 messenger RNA Proteins 0.000 description 3
• 239000002207 metabolite Substances 0.000 description 3
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 3
• 230000000877 morphologic effect Effects 0.000 description 3
• 238000010172 mouse model Methods 0.000 description 3
• 201000002273 mucopolysaccharidosis II Diseases 0.000 description 3
• 229960000951 mycophenolic acid Drugs 0.000 description 3
• 230000004770 neurodegeneration Effects 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 230000035699 permeability Effects 0.000 description 3
• 238000001907 polarising light microscopy Methods 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 239000000843 powder Substances 0.000 description 3
• 230000026447 protein localization Effects 0.000 description 3
• WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 3
• 229960000611 pyrimethamine Drugs 0.000 description 3
• 239000000600 sorbitol Substances 0.000 description 3
• 208000002320 spinal muscular atrophy Diseases 0.000 description 3
• 239000008107 starch Substances 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 239000013589 supplement Substances 0.000 description 3
• 108700012359 toxins Proteins 0.000 description 3
• 229960005486 vaccine Drugs 0.000 description 3
• 238000001262 western blot Methods 0.000 description 3
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
• 102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 2
• 102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 description 2
• 201000011452 Adrenoleukodystrophy Diseases 0.000 description 2
• 208000031277 Amaurotic familial idiocy Diseases 0.000 description 2
• 102100040006 Annexin A1 Human genes 0.000 description 2
• 241000224482 Apicomplexa Species 0.000 description 2
• 101100523496 Arabidopsis thaliana ARAC3 gene Proteins 0.000 description 2
• 101100523502 Arabidopsis thaliana ARAC5 gene Proteins 0.000 description 2
• 101100523506 Arabidopsis thaliana ARAC7 gene Proteins 0.000 description 2
• 101100523508 Arabidopsis thaliana ARAC8 gene Proteins 0.000 description 2
• 101100454739 Arabidopsis thaliana LUG gene Proteins 0.000 description 2
• 101100256915 Arabidopsis thaliana SIC gene Proteins 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 102100026031 Beta-glucuronidase Human genes 0.000 description 2
• 102100022549 Beta-hexosaminidase subunit beta Human genes 0.000 description 2
• 102100032912 CD44 antigen Human genes 0.000 description 2
• 102100022002 CD59 glycoprotein Human genes 0.000 description 2
• 102100037904 CD9 antigen Human genes 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• 241000238097 Callinectes sapidus Species 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 108010084457 Cathepsins Proteins 0.000 description 2
• 102000005600 Cathepsins Human genes 0.000 description 2
• 108091006146 Channels Proteins 0.000 description 2
• 208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 description 2
• 208000017667 Chronic Disease Diseases 0.000 description 2
• 101710149695 Clampless protein 1 Proteins 0.000 description 2
• 102100023691 Coiled-coil-helix-coiled-coil-helix domain-containing protein 5 Human genes 0.000 description 2
• 102100024330 Collectin-12 Human genes 0.000 description 2
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• AVVWPBAENSWJCB-GASJEMHNSA-N D-mannofuranose Chemical compound OC[C@@H](O)[C@H]1OC(O)[C@@H](O)[C@H]1O AVVWPBAENSWJCB-GASJEMHNSA-N 0.000 description 2
• 238000000116 DAPI staining Methods 0.000 description 2
• 230000004543 DNA replication Effects 0.000 description 2
• 206010011953 Decreased activity Diseases 0.000 description 2
• 102100035890 Delta(24)-sterol reductase Human genes 0.000 description 2
• 206010061818 Disease progression Diseases 0.000 description 2
• 102100026620 E3 ubiquitin ligase TRAF3IP2 Human genes 0.000 description 2
• 101710140859 E3 ubiquitin ligase TRAF3IP2 Proteins 0.000 description 2
• 101710179006 E3 ubiquitin-protein ligase parkin Proteins 0.000 description 2
• 102100022207 E3 ubiquitin-protein ligase parkin Human genes 0.000 description 2
• 108700039887 Essential Genes Proteins 0.000 description 2
• 208000028506 Familial Exudative Vitreoretinopathies Diseases 0.000 description 2
• 102100023364 Ganglioside GM2 activator Human genes 0.000 description 2
• 102100035902 Glutamate decarboxylase 1 Human genes 0.000 description 2
• 239000007995 HEPES buffer Substances 0.000 description 2
• 102100026973 Heat shock protein 75 kDa, mitochondrial Human genes 0.000 description 2
• 108010034791 Heterochromatin Proteins 0.000 description 2
• 101100161959 Homo sapiens ASPA gene Proteins 0.000 description 2
• 101000713904 Homo sapiens Activated RNA polymerase II transcriptional coactivator p15 Proteins 0.000 description 2
• 101000959738 Homo sapiens Annexin A1 Proteins 0.000 description 2
• 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 2
• 101001045433 Homo sapiens Beta-hexosaminidase subunit beta Proteins 0.000 description 2
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 2
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 2
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 2
• 101000906987 Homo sapiens Coiled-coil-helix-coiled-coil-helix domain-containing protein 5 Proteins 0.000 description 2
• 101000929877 Homo sapiens Delta(24)-sterol reductase Proteins 0.000 description 2
• 101100121090 Homo sapiens GALC gene Proteins 0.000 description 2
• 101000685969 Homo sapiens Ganglioside GM2 activator Proteins 0.000 description 2
• 101000873546 Homo sapiens Glutamate decarboxylase 1 Proteins 0.000 description 2
• 101001018939 Homo sapiens MICOS complex subunit MIC10 Proteins 0.000 description 2
• 101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 2
• 101000616876 Homo sapiens Mesencephalic astrocyte-derived neurotrophic factor Proteins 0.000 description 2
• 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 2
• 101000645296 Homo sapiens Metalloproteinase inhibitor 2 Proteins 0.000 description 2
• 101000982010 Homo sapiens Myelin proteolipid protein Proteins 0.000 description 2
• 101000651201 Homo sapiens N-sulphoglucosamine sulphohydrolase Proteins 0.000 description 2
• 101100241084 Homo sapiens NRTN gene Proteins 0.000 description 2
• 101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 description 2
• 101000973177 Homo sapiens Nuclear factor interleukin-3-regulated protein Proteins 0.000 description 2
• 101000579423 Homo sapiens Regulator of nonsense transcripts 1 Proteins 0.000 description 2
• 101001106432 Homo sapiens Rod outer segment membrane protein 1 Proteins 0.000 description 2
• 101000631760 Homo sapiens Sodium channel protein type 1 subunit alpha Proteins 0.000 description 2
• 101000828537 Homo sapiens Synaptic functional regulator FMR1 Proteins 0.000 description 2
• 101000598025 Homo sapiens Talin-1 Proteins 0.000 description 2
• 101000837841 Homo sapiens Transcription factor EB Proteins 0.000 description 2
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 108700002232 Immediate-Early Genes Proteins 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• 208000024889 MECP2 duplication syndrome Diseases 0.000 description 2
• 102100033551 MICOS complex subunit MIC10 Human genes 0.000 description 2
• 102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• 101001129124 Mannheimia haemolytica Outer membrane lipoprotein 1 Proteins 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 2
• 102100021833 Mesencephalic astrocyte-derived neurotrophic factor Human genes 0.000 description 2
• 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 description 2
• 108020005196 Mitochondrial DNA Proteins 0.000 description 2
• 102100040200 Mitochondrial uncoupling protein 2 Human genes 0.000 description 2
• 206010056886 Mucopolysaccharidosis I Diseases 0.000 description 2
• 208000000149 Multiple Sulfatase Deficiency Disease Diseases 0.000 description 2
• 208000035032 Multiple sulfatase deficiency Diseases 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 102100026784 Myelin proteolipid protein Human genes 0.000 description 2
• 102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 description 2
• 208000012902 Nervous system disease Diseases 0.000 description 2
• 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 description 2
• 208000025966 Neurological disease Diseases 0.000 description 2
• 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 2
• 101100007538 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cpc-1 gene Proteins 0.000 description 2
• 102100021584 Neurturin Human genes 0.000 description 2
• 102000007999 Nuclear Proteins Human genes 0.000 description 2
• 108010089610 Nuclear Proteins Proteins 0.000 description 2
• 102100022163 Nuclear factor interleukin-3-regulated protein Human genes 0.000 description 2
• 208000008589 Obesity Diseases 0.000 description 2
• 101000761187 Odontomachus monticola U-poneritoxin(01)-Om1a Proteins 0.000 description 2
• 101100523501 Oryza sativa subsp. japonica RAC4 gene Proteins 0.000 description 2
• 102000019233 PAN/Apple domains Human genes 0.000 description 2
• 108050006546 PAN/Apple domains Proteins 0.000 description 2
• 108010032788 PAX6 Transcription Factor Proteins 0.000 description 2
• 102100037506 Paired box protein Pax-6 Human genes 0.000 description 2
• 102000005327 Palmitoyl protein thioesterase Human genes 0.000 description 2
• 108020002591 Palmitoyl protein thioesterase Proteins 0.000 description 2
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
• 208000033876 Proximal Xq28 duplication syndrome Diseases 0.000 description 2
• 230000006819 RNA synthesis Effects 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 102100028287 Regulator of nonsense transcripts 1 Human genes 0.000 description 2
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 2
• 102100021424 Rod outer segment membrane protein 1 Human genes 0.000 description 2
• 229910004444 SUB1 Inorganic materials 0.000 description 2
• 229910004438 SUB2 Inorganic materials 0.000 description 2
• 101100067993 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ASC1 gene Proteins 0.000 description 2
• 101100494218 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) BRP1 gene Proteins 0.000 description 2
• 101100067991 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rkp1 gene Proteins 0.000 description 2
• 101100311330 Schizosaccharomyces pombe (strain 972 / ATCC 24843) uap56 gene Proteins 0.000 description 2
• 208000034189 Sclerosis Diseases 0.000 description 2
• 102000005473 Secretory Phospholipases A2 Human genes 0.000 description 2
• 108010031873 Secretory Phospholipases A2 Proteins 0.000 description 2
• 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 2
• 102100028910 Sodium channel protein type 1 subunit alpha Human genes 0.000 description 2
• 108090000787 Subtilisin Proteins 0.000 description 2
• 102300033377 Survival motor neuron protein isoform SMN Human genes 0.000 description 2
• 102100023532 Synaptic functional regulator FMR1 Human genes 0.000 description 2
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
• 102100036977 Talin-1 Human genes 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• 101100305998 Toxoplasma gondii (strain ATCC 50611 / Me49) RON2 gene Proteins 0.000 description 2
• 101100122821 Toxoplasma gondii GRA3 gene Proteins 0.000 description 2
• 101100345585 Toxoplasma gondii MIC6 gene Proteins 0.000 description 2
• 101100305999 Toxoplasma gondii RON4 gene Proteins 0.000 description 2
• 101100198869 Toxoplasma gondii ROP4 gene Proteins 0.000 description 2
• 101710204707 Transforming growth factor-beta receptor-associated protein 1 Proteins 0.000 description 2
• 101000862137 Trichoderma koningii Glyceraldehyde-3-phosphate dehydrogenase 1 Proteins 0.000 description 2
• 108010039203 Tripeptidyl-Peptidase 1 Proteins 0.000 description 2
• 102100034197 Tripeptidyl-peptidase 1 Human genes 0.000 description 2
• 108010021111 Uncoupling Protein 2 Proteins 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 108010067390 Viral Proteins Proteins 0.000 description 2
• 208000027418 Wounds and injury Diseases 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 239000012574 advanced DMEM Substances 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 230000036506 anxiety Effects 0.000 description 2
• 230000005775 apoptotic pathway Effects 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 244000309464 bull Species 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 101150102092 ccdB gene Proteins 0.000 description 2
• 210000005056 cell body Anatomy 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 229960005091 chloramphenicol Drugs 0.000 description 2
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 238000012937 correction Methods 0.000 description 2
• 230000001054 cortical effect Effects 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 230000007547 defect Effects 0.000 description 2
• 230000006735 deficit Effects 0.000 description 2
• 230000007850 degeneration Effects 0.000 description 2
• 230000002939 deleterious effect Effects 0.000 description 2
• 210000001787 dendrite Anatomy 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 210000003520 dendritic spine Anatomy 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 230000005750 disease progression Effects 0.000 description 2
• 230000004064 dysfunction Effects 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 238000013401 experimental design Methods 0.000 description 2
• 201000006902 exudative vitreoretinopathy Diseases 0.000 description 2
• 239000010685 fatty oil Substances 0.000 description 2
• 239000000945 filler Substances 0.000 description 2
• 238000002073 fluorescence micrograph Methods 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 230000037406 food intake Effects 0.000 description 2
• 210000003953 foreskin Anatomy 0.000 description 2
• 230000003371 gabaergic effect Effects 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 235000021474 generally recognized As safe (food) Nutrition 0.000 description 2
• 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 2
• 210000004602 germ cell Anatomy 0.000 description 2
• 230000003394 haemopoietic effect Effects 0.000 description 2
• 210000004458 heterochromatin Anatomy 0.000 description 2
• 102000048753 human TFEB Human genes 0.000 description 2
• 238000003384 imaging method Methods 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 208000014674 injury Diseases 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 244000000056 intracellular parasite Species 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000007913 intrathecal administration Methods 0.000 description 2
• 208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 description 2
• 231100000518 lethal Toxicity 0.000 description 2
• 230000001665 lethal effect Effects 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 210000003141 lower extremity Anatomy 0.000 description 2
• 239000006166 lysate Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 108091070501 miRNA Proteins 0.000 description 2
• 239000002679 microRNA Substances 0.000 description 2
• 230000004899 motility Effects 0.000 description 2
• 230000004973 motor coordination Effects 0.000 description 2
• 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 239000002105 nanoparticle Substances 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 230000002314 neuroinflammatory effect Effects 0.000 description 2
• 201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 description 2
• 230000006764 neuronal dysfunction Effects 0.000 description 2
• 235000020824 obesity Nutrition 0.000 description 2
• 230000036284 oxygen consumption Effects 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 230000035515 penetration Effects 0.000 description 2
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
• 230000008488 polyadenylation Effects 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 231100000683 possible toxicity Toxicity 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 230000004952 protein activity Effects 0.000 description 2
• 238000001243 protein synthesis Methods 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 230000000241 respiratory effect Effects 0.000 description 2
• 230000029058 respiratory gaseous exchange Effects 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 230000001953 sensory effect Effects 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 230000003997 social interaction Effects 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 208000020431 spinal cord injury Diseases 0.000 description 2
• 238000009168 stem cell therapy Methods 0.000 description 2
• 238000009580 stem-cell therapy Methods 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 229960005322 streptomycin Drugs 0.000 description 2
• 101150018444 sub2 gene Proteins 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 210000000225 synapse Anatomy 0.000 description 2
• 230000000946 synaptic effect Effects 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 108091006106 transcriptional activators Proteins 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 description 1
• LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 1
• GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
• HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
• 101150101112 7 gene Proteins 0.000 description 1
• 101710201407 ATP synthase F(0) complex subunit B1, mitochondrial Proteins 0.000 description 1
• 102100023619 ATP synthase F(0) complex subunit B1, mitochondrial Human genes 0.000 description 1
• 101710115740 ATP synthase subunit 4, mitochondrial Proteins 0.000 description 1
• 101710129138 ATP synthase subunit 9, mitochondrial Proteins 0.000 description 1
• 102100021921 ATP synthase subunit a Human genes 0.000 description 1
• 101710114070 ATP synthase subunit a Proteins 0.000 description 1
• 101710114068 ATP synthase subunit b Proteins 0.000 description 1
• 101710114069 ATP synthase subunit c Proteins 0.000 description 1
• 101710193701 ATP synthase subunit delta Proteins 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 102100035028 Alpha-L-iduronidase Human genes 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 102100034561 Alpha-N-acetylglucosaminidase Human genes 0.000 description 1
• 208000009575 Angelman syndrome Diseases 0.000 description 1
• 206010073129 Angiocentric glioma Diseases 0.000 description 1
• 108010064733 Angiotensins Proteins 0.000 description 1
• 108010049777 Ankyrins Proteins 0.000 description 1
• 102000008102 Ankyrins Human genes 0.000 description 1
• 108090000668 Annexin A2 Proteins 0.000 description 1
• 101710203310 Apical membrane antigen 1 Proteins 0.000 description 1
• 101000873533 Arabidopsis thaliana Glutamate decarboxylase 1 Proteins 0.000 description 1
• 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 1
• 108700019265 Aromatic amino acid decarboxylase deficiency Proteins 0.000 description 1
• 206010068220 Aspartylglucosaminuria Diseases 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 201000004569 Blindness Diseases 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 206010048962 Brain oedema Diseases 0.000 description 1
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
• 208000036875 CNGB3-related retinopathy Diseases 0.000 description 1
• 101100084118 Caenorhabditis elegans ppt-1 gene Proteins 0.000 description 1
• 101100140896 Caenorhabditis elegans rgs-2 gene Proteins 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 102100029226 Cancer-related nucleoside-triphosphatase Human genes 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 102000004225 Cathepsin B Human genes 0.000 description 1
• 108090000712 Cathepsin B Proteins 0.000 description 1
• 108010051109 Cell-Penetrating Peptides Proteins 0.000 description 1
• 102000020313 Cell-Penetrating Peptides Human genes 0.000 description 1
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
• 102100035345 Cerebral dopamine neurotrophic factor Human genes 0.000 description 1
• 101710203678 Chitinase-like protein Proteins 0.000 description 1
• 206010008583 Chloroma Diseases 0.000 description 1
• 101100098873 Chondrus crispus TUBB gene Proteins 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
• 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
• 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
• 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
• 208000003322 Coinfection Diseases 0.000 description 1
• 206010010144 Completed suicide Diseases 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
• 102100038387 Cystatin-SN Human genes 0.000 description 1
• 102100031461 Cytochrome P450 2J2 Human genes 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
• 108091075378 DJ-1 family Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• 208000016192 Demyelinating disease Diseases 0.000 description 1
• 206010012305 Demyelination Diseases 0.000 description 1
• 102100022874 Dexamethasone-induced Ras-related protein 1 Human genes 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• 101100427383 Dictyostelium discoideum uch1 gene Proteins 0.000 description 1
• 102100031675 DnaJ homolog subfamily C member 5 Human genes 0.000 description 1
• 201000010374 Down Syndrome Diseases 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 101710088791 Elongation factor 2 Proteins 0.000 description 1
• 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 241000792859 Enema Species 0.000 description 1
• 101710181478 Envelope glycoprotein GP350 Proteins 0.000 description 1
• 241000713730 Equine infectious anemia virus Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 208000024720 Fabry Disease Diseases 0.000 description 1
• 241000713800 Feline immunodeficiency virus Species 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 102100028875 Formylglycine-generating enzyme Human genes 0.000 description 1
• 208000001914 Fragile X syndrome Diseases 0.000 description 1
• 201000011240 Frontotemporal dementia Diseases 0.000 description 1
• 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
• 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
• 201000008892 GM1 Gangliosidosis Diseases 0.000 description 1
• 101150010973 GRA1 gene Proteins 0.000 description 1
• 208000017462 Galactosialidosis Diseases 0.000 description 1
• 208000015872 Gaucher disease Diseases 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• 208000000527 Germinoma Diseases 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 1
• 206010053185 Glycogen storage disease type II Diseases 0.000 description 1
• 206010060980 Granular cell tumour Diseases 0.000 description 1
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
• 102100040896 Growth/differentiation factor 15 Human genes 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 108091006013 HA-tagged proteins Proteins 0.000 description 1
• 239000012981 Hank's balanced salt solution Substances 0.000 description 1
• 102100028006 Heme oxygenase 1 Human genes 0.000 description 1
• 102100039991 Heparan-alpha-glucosaminide N-acetyltransferase Human genes 0.000 description 1
• 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 101001019502 Homo sapiens Alpha-L-iduronidase Proteins 0.000 description 1
• 101000738349 Homo sapiens CD99 antigen Proteins 0.000 description 1
• 101000737775 Homo sapiens Cerebral dopamine neurotrophic factor Proteins 0.000 description 1
• 101000884768 Homo sapiens Cystatin-SN Proteins 0.000 description 1
• 101000941723 Homo sapiens Cytochrome P450 2J2 Proteins 0.000 description 1
• 101000620808 Homo sapiens Dexamethasone-induced Ras-related protein 1 Proteins 0.000 description 1
• 101000845893 Homo sapiens DnaJ homolog subfamily C member 5 Proteins 0.000 description 1
• 101000648611 Homo sapiens Formylglycine-generating enzyme Proteins 0.000 description 1
• 101000860395 Homo sapiens Galactocerebrosidase Proteins 0.000 description 1
• 101000997829 Homo sapiens Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 description 1
• 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 description 1
• 101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 description 1
• 101001035092 Homo sapiens Heparan-alpha-glucosaminide N-acetyltransferase Proteins 0.000 description 1
• 101000979046 Homo sapiens Lysosomal alpha-mannosidase Proteins 0.000 description 1
• 101000634196 Homo sapiens Neurotrophin-3 Proteins 0.000 description 1
• 101000996052 Homo sapiens Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 Proteins 0.000 description 1
• 101100191388 Homo sapiens PRKN gene Proteins 0.000 description 1
• 101000619805 Homo sapiens Peroxiredoxin-5, mitochondrial Proteins 0.000 description 1
• 101000619708 Homo sapiens Peroxiredoxin-6 Proteins 0.000 description 1
• 101000692878 Homo sapiens Regulator of MON1-CCZ1 complex Proteins 0.000 description 1
• 101000963987 Homo sapiens SH3 domain-binding protein 5 Proteins 0.000 description 1
• 101000605835 Homo sapiens Serine/threonine-protein kinase PINK1, mitochondrial Proteins 0.000 description 1
• 101001026232 Homo sapiens Small conductance calcium-activated potassium channel protein 3 Proteins 0.000 description 1
• 101000785978 Homo sapiens Sphingomyelin phosphodiesterase Proteins 0.000 description 1
• 101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 1
• 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 description 1
• 101001090050 Homo sapiens Thioredoxin-dependent peroxide reductase, mitochondrial Proteins 0.000 description 1
• 101000893741 Homo sapiens Tissue alpha-L-fucosidase Proteins 0.000 description 1
• 101000772888 Homo sapiens Ubiquitin-protein ligase E3A Proteins 0.000 description 1
• 101000742579 Homo sapiens Vascular endothelial growth factor B Proteins 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 208000015178 Hurler syndrome Diseases 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 239000007836 KH2PO4 Substances 0.000 description 1
• 208000017119 Labyrinth disease Diseases 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 241000186781 Listeria Species 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 1
• 102100023231 Lysosomal alpha-mannosidase Human genes 0.000 description 1
• 101150083522 MECP2 gene Proteins 0.000 description 1
• 108010018650 MEF2 Transcription Factors Proteins 0.000 description 1
• 235000019759 Maize starch Nutrition 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 1
• 102000006890 Methyl-CpG-Binding Protein 2 Human genes 0.000 description 1
• 206010056893 Mucopolysaccharidosis VII Diseases 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 101100129193 Mus musculus Man2b1 gene Proteins 0.000 description 1
• 101100521345 Mus musculus Prop1 gene Proteins 0.000 description 1
• 102100039229 Myocyte-specific enhancer factor 2C Human genes 0.000 description 1
• 102100031455 NAD-dependent protein deacetylase sirtuin-1 Human genes 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 201000004404 Neurofibroma Diseases 0.000 description 1
• 102100029268 Neurotrophin-3 Human genes 0.000 description 1
• 102100034451 Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 Human genes 0.000 description 1
• 208000025464 Norrie disease Diseases 0.000 description 1
• 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
• 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
• 108010075285 Nucleoside-Triphosphatase Proteins 0.000 description 1
• 206010048757 Oncocytoma Diseases 0.000 description 1
• 208000026251 Opioid-Related disease Diseases 0.000 description 1
• 208000002063 Oxyphilic Adenoma Diseases 0.000 description 1
• 229930012538 Paclitaxel Natural products 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 201000008789 Perineurioma Diseases 0.000 description 1
• 208000031839 Peripheral nerve sheath tumour malignant Diseases 0.000 description 1
• 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 1
• 102100022078 Peroxiredoxin-5, mitochondrial Human genes 0.000 description 1
• LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 1
• 108010035235 Phleomycins Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
• 208000021308 Pituicytoma Diseases 0.000 description 1
• 208000007452 Plasmacytoma Diseases 0.000 description 1
• 108030005449 Polo kinases Proteins 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 108700017836 Prophet of Pit-1 Proteins 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 101710149951 Protein Tat Proteins 0.000 description 1
• 102100036352 Protein disulfide-isomerase Human genes 0.000 description 1
• 102000006831 Protein phosphatase 2C Human genes 0.000 description 1
• 108010047313 Protein phosphatase 2C Proteins 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 101710196562 RNA helicase NPH-II Proteins 0.000 description 1
• 208000037644 RPE65-related recessive retinopathy Diseases 0.000 description 1
• 102100021258 Regulator of G-protein signaling 2 Human genes 0.000 description 1
• 101710140412 Regulator of G-protein signaling 2 Proteins 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 201000007527 Retinal artery occlusion Diseases 0.000 description 1
• 108030003231 Rhomboid proteases Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 102100040119 SH3 domain-binding protein 5 Human genes 0.000 description 1
• 108091006650 SLC9A2 Proteins 0.000 description 1
• 101001068777 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GTPase-activating protein GYP2 Proteins 0.000 description 1
• 101001024423 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 Proteins 0.000 description 1
• 201000002883 Scheie syndrome Diseases 0.000 description 1
• 102100038376 Serine/threonine-protein kinase PINK1, mitochondrial Human genes 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 108010041191 Sirtuin 1 Proteins 0.000 description 1
• 201000001828 Sly syndrome Diseases 0.000 description 1
• 102100037442 Small conductance calcium-activated potassium channel protein 3 Human genes 0.000 description 1
• 102100030382 Sodium/hydrogen exchanger 2 Human genes 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• 101100483128 Solanum tuberosum TUB8 gene Proteins 0.000 description 1
• 102100026263 Sphingomyelin phosphodiesterase Human genes 0.000 description 1
• 102100025750 Sphingosine 1-phosphate receptor 1 Human genes 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 206010042566 Superinfection Diseases 0.000 description 1
• 101150114468 TUB1 gene Proteins 0.000 description 1
• 101150025182 TUBB1 gene Proteins 0.000 description 1
• 101150073866 TUBB8 gene Proteins 0.000 description 1
• 101100451295 Takifugu rubripes hmox gene Proteins 0.000 description 1
• 206010043276 Teratoma Diseases 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 102100034769 Thioredoxin-dependent peroxide reductase, mitochondrial Human genes 0.000 description 1
• 108060008245 Thrombospondin Proteins 0.000 description 1
• 102000002938 Thrombospondin Human genes 0.000 description 1
• 102100040526 Tissue alpha-L-fucosidase Human genes 0.000 description 1
• 101100057102 Toxoplasma gondii (strain ATCC 50611 / Me49) ApiAT1 gene Proteins 0.000 description 1
• 101000871058 Toxoplasma gondii Dense granule protein 1 Proteins 0.000 description 1
• 101001009608 Toxoplasma gondii Dense granule protein 4 Proteins 0.000 description 1
• 101001009612 Toxoplasma gondii Dense granule protein 6 Proteins 0.000 description 1
• 101001009614 Toxoplasma gondii Dense granule protein 7 Proteins 0.000 description 1
• 101100069381 Toxoplasma gondii GRA4 gene Proteins 0.000 description 1
• 101100069385 Toxoplasma gondii GRA6 gene Proteins 0.000 description 1
• 101100069387 Toxoplasma gondii GRA7 gene Proteins 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 101710205823 Translation elongation factor 2 Proteins 0.000 description 1
• 239000007984 Tris EDTA buffer Substances 0.000 description 1
• 102000002501 Tryptophan-tRNA Ligase Human genes 0.000 description 1
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
• 102000005918 Ubiquitin Thiolesterase Human genes 0.000 description 1
• 108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 1
• 102100030434 Ubiquitin-protein ligase E3A Human genes 0.000 description 1
• 102100038217 Vascular endothelial growth factor B Human genes 0.000 description 1
• 201000010802 Wolfram syndrome Diseases 0.000 description 1
• 208000010796 X-linked adrenoleukodystrophy Diseases 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 229940040563 agaric acid Drugs 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 108010009380 alpha-N-acetyl-D-glucosaminidase Proteins 0.000 description 1
• 201000008333 alpha-mannosidosis Diseases 0.000 description 1
• 101150078331 ama-1 gene Proteins 0.000 description 1
• 206010001902 amaurosis Diseases 0.000 description 1
• 230000001668 ameliorated effect Effects 0.000 description 1
• 201000002781 amyotrophic lateral sclerosis type 9 Diseases 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• 101150010487 are gene Proteins 0.000 description 1
• 201000004001 aromatic L-amino acid decarboxylase deficiency Diseases 0.000 description 1
• 201000005476 astroblastoma Diseases 0.000 description 1
• 230000003140 astrocytic effect Effects 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 208000010767 autosomal recessive early-onset Parkinson disease 6 Diseases 0.000 description 1
• 230000003376 axonal effect Effects 0.000 description 1
• 206010003882 axonal neuropathy Diseases 0.000 description 1
• 230000037429 base substitution Effects 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 230000003925 brain function Effects 0.000 description 1
• 210000005013 brain tissue Anatomy 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 235000011148 calcium chloride Nutrition 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229960004424 carbon dioxide Drugs 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 210000001715 carotid artery Anatomy 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000004709 cell invasion Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 238000002659 cell therapy Methods 0.000 description 1
• 230000033077 cellular process Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 208000013940 chordoid glioma of the third ventricle Diseases 0.000 description 1
• 210000002987 choroid plexus Anatomy 0.000 description 1
• 238000002487 chromatin immunoprecipitation Methods 0.000 description 1
• 230000008045 co-localization Effects 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 210000004351 coronary vessel Anatomy 0.000 description 1
• 101150027734 cript gene Proteins 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 239000000412 dendrimer Substances 0.000 description 1
• 229920000736 dendritic polymer Polymers 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 210000002249 digestive system Anatomy 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
• 235000019797 dipotassium phosphate Nutrition 0.000 description 1
• 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 230000003291 dopaminomimetic effect Effects 0.000 description 1
• 230000005782 double-strand break Effects 0.000 description 1
• 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 208000001991 endodermal sinus tumor Diseases 0.000 description 1
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 239000007920 enema Substances 0.000 description 1
• 229940079360 enema for constipation Drugs 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000026502 entry into host cell Effects 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
• 238000010228 ex vivo assay Methods 0.000 description 1
• 231100000318 excitotoxic Toxicity 0.000 description 1
• 230000003492 excitotoxic effect Effects 0.000 description 1
• 210000001723 extracellular space Anatomy 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 210000001508 eye Anatomy 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 229960000555 fenyramidol Drugs 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
• 229960004413 flucytosine Drugs 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 201000008049 fucosidosis Diseases 0.000 description 1
• IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
• 229960002963 ganciclovir Drugs 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 229960002518 gentamicin Drugs 0.000 description 1
• 201000003115 germ cell cancer Diseases 0.000 description 1
• 201000003382 giant axonal neuropathy 1 Diseases 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 101150091511 glb-1 gene Proteins 0.000 description 1
• 229960002743 glutamine Drugs 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 201000004502 glycogen storage disease II Diseases 0.000 description 1
• 230000002710 gonadal effect Effects 0.000 description 1
• 208000017750 granulocytic sarcoma Diseases 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 210000005003 heart tissue Anatomy 0.000 description 1
• 201000002222 hemangioblastoma Diseases 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 230000000971 hippocampal effect Effects 0.000 description 1
• 102000052654 human GDNF Human genes 0.000 description 1
• 102000053565 human SMN1 Human genes 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 238000010191 image analysis Methods 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 238000010185 immunofluorescence analysis Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 230000001861 immunosuppressant effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 238000002743 insertional mutagenesis Methods 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 210000004347 intestinal mucosa Anatomy 0.000 description 1
• 238000000185 intracerebroventricular administration Methods 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 230000002045 lasting effect Effects 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 231100000225 lethality Toxicity 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 229940057995 liquid paraffin Drugs 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 210000003712 lysosome Anatomy 0.000 description 1
• 230000001868 lysosomic effect Effects 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 201000009020 malignant peripheral nerve sheath tumor Diseases 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 210000002418 meninge Anatomy 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 230000002906 microbiologic effect Effects 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 201000009057 mixed germ cell cancer Diseases 0.000 description 1
• 208000024252 mixed germ cell tumor Diseases 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000001483 mobilizing effect Effects 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• 210000002161 motor neuron Anatomy 0.000 description 1
• 208000036725 mucopolysaccharidosis type 3D Diseases 0.000 description 1
• 208000025919 mucopolysaccharidosis type 7 Diseases 0.000 description 1
• 208000027333 mucopolysaccharidosis type IIID Diseases 0.000 description 1
• 210000004400 mucous membrane Anatomy 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 201000005987 myeloid sarcoma Diseases 0.000 description 1
• 239000002539 nanocarrier Substances 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 208000023833 nerve sheath neoplasm Diseases 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 208000007538 neurilemmoma Diseases 0.000 description 1
• 208000027831 neuroepithelial neoplasm Diseases 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 230000035771 neuroregeneration Effects 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 201000005040 opiate dependence Diseases 0.000 description 1
• 230000014207 opsonization Effects 0.000 description 1
• 208000001749 optic atrophy Diseases 0.000 description 1
• 208000020911 optic nerve disease Diseases 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 239000003791 organic solvent mixture Substances 0.000 description 1
• 229960001592 paclitaxel Drugs 0.000 description 1
• 208000021090 palsy Diseases 0.000 description 1
• 210000004923 pancreatic tissue Anatomy 0.000 description 1
• 108700007244 parkin Proteins 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 239000000049 pigment Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 208000028173 post-traumatic stress disease Diseases 0.000 description 1
• GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 239000000955 prescription drug Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 238000012514 protein characterization Methods 0.000 description 1
• 108020003519 protein disulfide isomerase Proteins 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 230000020978 protein processing Effects 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 230000012743 protein tagging Effects 0.000 description 1
• 238000009163 protein therapy Methods 0.000 description 1
• 244000000040 protozoan parasite Species 0.000 description 1
• 210000004879 pulmonary tissue Anatomy 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 210000005084 renal tissue Anatomy 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 210000001525 retina Anatomy 0.000 description 1
• 229940100486 rice starch Drugs 0.000 description 1
• 239000000523 sample Substances 0.000 description 1
• 206010039667 schwannoma Diseases 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• 201000005572 sensory peripheral neuropathy Diseases 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 239000012439 solid excipient Substances 0.000 description 1
• 239000002047 solid lipid nanoparticle Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 210000003046 sporozoite Anatomy 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 238000002660 stem cell treatment Methods 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 230000001502 supplementing effect Effects 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000002511 suppository base Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 208000006379 syphilis Diseases 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 230000007723 transport mechanism Effects 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 230000002861 ventricular Effects 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 229940100445 wheat starch Drugs 0.000 description 1